Aardvark Therapeutics
(NASDAQ) AARD
Aardvark Therapeutics Financials at a Glance
Market Cap
$76.57M
Revenue (TTM)
$0.00
Net Income (TTM)
$57.59M
EPS (TTM)
$-2.65
P/E Ratio
-1.33
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$3.51
Volume
5,017
Open
$3.51
Price
$3.51
Volume
5,017
Open
$3.51
Previous Close
$3.51
Daily Range
$3.41 - $3.65
52-Week Range
$3.40 - $17.94
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$3.51
Volume
5,017
Open
$3.51
Previous Close
$3.51
Daily Range
$3.41 - $3.65
52-Week Range
$3.40 - $17.94
AARD News
AARD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aardvark Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
40
CEO
Tien Li Lee, MD
Website
www.aardvarktherapeutics.comHeadquarters
San Diego, CA 92122, US
AARD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-64%
Return on Capital
-59%
Return on Assets
-49%
Earnings Yield
-75.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$76.57M
Shares Outstanding
21.82M
Volume
5.02K
Short Interest
0.00%
Avg. Volume
281.64K
Financials (TTM)
Gross Profit
$36.00K
Operating Income
$62.73M
EBITDA
$62.73M
Operating Cash Flow
$54.17M
Capital Expenditure
$95.00K
Free Cash Flow
$54.27M
Cash & ST Invst.
$110.03M
Total Debt
$441.00K
Aardvark Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$10.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$76.57M
N/A
Market Cap/Employee
$3.48M
N/A
Employees
22
N/A
Net Income
$17.60M
-100.5%
EBITDA
$18.69M
-98.0%
Quarterly Fundamentals
Net Cash
$109.59M
+50.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$441.00K
+30.5%
Return on Assets
-49.15%
N/A
Return on Invested Capital
-58.82%
N/A
Free Cash Flow
$14.42M
-86.5%
Operating Cash Flow
$14.42M
-86.7%